Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
2
×
rna interference
san francisco blog main
san francisco top stories
akcea therapeutics
alexion pharmaceuticals
alnylam pharmaceutials
alnylam pharmaceuticals
andrew fire
arrowhead pharmaceuticals
biotech
boehringer ingelheim
craig mello
deals
dicerna pharmaceuticals
eli lilly
fda
hepatitis b
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
john maraganore
johnson & johnson
neurodegenerative diseases
new york blog main
new york top stories
nobel prize
onpattro
patisiran
pfizer
primary hyperoxaluria
san diego blog main
san diego top stories
What
gets
2
×
rnai
2
×
abandoning
afternoon
ago
alnylam
alnylam’s
approved
baggage
companies
cuts
deal
development
dicerna
drug
fda
free
history
interference
landmark
long
making
medicine
medicines
ok
onpattro
patisiran
pharma
pharmaceuticals
rna
signs
small
specifically
wasn’t
Language
Current search:
rnai
×
" national top stories "
×
gets
×
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug